Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - DUSA PHARMACEUTICALS INC | y83067e10vk.htm |
| EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y83067exv99w1.htm |
| EX-31.B - EX-31.B - DUSA PHARMACEUTICALS INC | y83067exv31wb.htm |
| EX-21.A - EX-21.A - DUSA PHARMACEUTICALS INC | y83067exv21wa.htm |
| EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y83067exv32wb.htm |
| EX-23.A - EX-23.A - DUSA PHARMACEUTICALS INC | y83067exv23wa.htm |
| EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y83067exv31wa.htm |
EXHIBIT 32(a)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of DUSA Pharmaceuticals, Inc. (the “Company”)
on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange
Commission (the “Report”), I, Robert F. Doman, President and Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
| Date: March 4, 2010 | /s/ Robert F. Doman | |||
| Robert F. Doman | ||||
| President and Chief Executive Officer (principal executive officer) |
||||